Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

The method allows for 3D tracking of hair follicle stem cells and shows they can regenerate hair for up to 180 days.

Blocking testosterone speeds up wound healing in males.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Blocking testosterone speeds up wound healing in males.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Mutations in the Vitamin D receptor gene can cause hair loss similar to mutations in the Hairless gene.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Sex hormones affect brain injury differently in males and females.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Blackcurrant extract may help reduce hair loss by promoting stem cell activity in hair follicles.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.